|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | (2006.01) |
| A61K 31/416 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/5355 | (2006.01) | ||
| A61K 31/555 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/32 | (2006.01) |
| (11) | Number of the document | 3269366 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17167567.1 |
| Date of filing the European patent application | 2009-03-10 | |
| (97) | Date of publication of the European application | 2018-01-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 37410 P | 2008-03-18 | US |
| (72) |
BERRY, Leanne, US
PHILLIPS, Gail, Lewis, US
SLIWKOWSKI, Mark, X., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND LAPATINIB, AND METHODS OF USE |
| COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND LAPATINIB, AND METHODS OF USE |